The Med-Tech company PolarCool AB (publ.) has signed an agreement with football club 1. FC Köln, who compete in the second tier of the German Bundesliga. The agreement includes an initial evaluation period, followed by a two-year commercial contract.

This deal represents a significant step into the German football market for PolarCool. The company already has a strong foothold in German ice hockey, with the majority of DEL (Deutsche Eishockey Liga) clubs utilizing PolarCap®.

While head injuries are more prevalent in ice hockey and rugby, football is emerging as an increasingly important market for PolarCool. Although less frequent, head injuries in football still present serious challenges for players and financial implications for clubs. As awareness grows, PolarCool is seeing increased interest from several top European football clubs.

1. FC Köln’s Medical Coordinator Christian Osebold comments;

-Actively working on player welfare and health is a top priority for us at 1. FC Köln. The scientific evidence behind PolarCap® is compelling. I now look forward to be able to provide acute treatment for my players in the event of concussions, and with that reducing the risk of long-term absences.

PolarCool’s CEO, Erik Andersson comments;

-With our ambition to expand within European football, we are very pleased to begin this collaboration with 1. FC Köln, a prestigious club in German football. Germany is a key market in Europe, along with others such as France and the United Kingdom. We have been particularly successful in ice hockey and rugby in these countries, which has increased interest from football clubs.

The agreement is financially limited but is considered a strategically important breakthrough in the German market.

For more information

Erik Andersson –  CEO PolarCool AB (publ.)               
+46 - 738 60 57 00                                         
E-mail: erik.andersson@polarcool.se

About PolarCool AB (publ.)

PolarCool AB (publ.) is a medical device company that develops, markets, and sells products for sports medicine. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap®. PolarCool AB (publ.) is based in Lund, Sweden, and its shares are listed on Spotlight Stock Market.